Accessibility Menu
Medical Developments International logo

Medical Developments International(OTC) MDDVF

Market Cap$41.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-94%
5 Year-93%
1 Year-27%
1 Month-0%
$0.37
+0%
+0.00Today
Medical Developments International last closing stock price
MetricPriceDate
Last closeUSD 0.372026-05-06
Medical Developments International stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.18%USD 0.372026-01-09
1 month-0.18%USD 0.372026-01-09
3 month-0.18%USD 0.372026-01-09
Year to date+21.79%USD 0.302025-12-17
1 year-27.11%USD 0.512025-02-21
3 year-41.72%USD 0.632023-05-03
5 year-92.6%USD 5.002021-04-20
Since inception-94.29%USD 6.482020-01-21

Medical Developments International Financials at a Glance

Market Cap

$41.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$78.69M

Net Income (TTM)

-A$30.18M

EPS (TTM)

-$0.00

P/E Ratio

-148.00

Dividend

$0.00

Beta (Volatility)

0.24 (Low)

Price

$0.37

Volume

20,000

Open

$0.37

Previous Close

$0.37

Daily Range

$0.37 - $0.37

52-Week Range

$0.30 - $0.37

Estimated Earnings Date

Aug 20, 2026

MDDVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medical Developments International

Medical Developments International Limited is a global provider of essential medical solutions, engaged in both manufacturing and distribution. The company operates primarily in two segments: Pain Management and Respiratory, offering innovative products to improve patient care.

Products and Services
  • Penthrox, a key pain relief product for trauma and emergency situations
  • Devices for asthma and chronic obstructive pulmonary disease management
  • Diverse medical instruments, including CPR equipment and oxygen therapy kits
Growth Outlook
  • Recent quarterly revenue reached AUD 21.56 million, indicating strong market demand
  • Expansion into international markets enhances growth potential
  • Continued investment in R&D supports product innovation and market competitiveness
Financial Highlights
  • Trailing twelve months revenue of AUD 73.5 million reflects a solid performance
  • Current ratio of 6.07 indicates strong liquidity position
  • Net income margin remains negative, highlighting areas for operational improvement
Medical Developments International Limited is positioned to capitalize on the growing demand for effective medical solutions. The company's focus on pain management and respiratory care aligns with global health trends, making it a noteworthy player in the healthcare sector. With a robust product portfolio and a commitment to innovation, the company is well-equipped to navigate the challenges of the medical industry. Investors may find the company's strategic initiatives and financial metrics indicative of its potential for future growth.
AI Generated • Jul 26, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Brent MacGregor, MBA

Website

www.medicaldev.com

Headquarters

Scoresby, VIC 3179, AU

MDDVF Financials

Key Financial Metrics (TTM)

Gross Margin

52.71%

Operating Margin

0.83%

Net Income Margin

-1.07%

Return on Equity

-0.79%

Return on Capital

5.38%

Return on Assets

-0.69%

Earnings Yield

-0.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

112.66M

Volume

20.00K

Avg. Volume

322.581

Financials (TTM)

Gross Profit

A$39.09M

Operating Income

-A$830.99K

EBITDA

-A$13.56M

Operating Cash Flow

-A$4.09M

Capital Expenditure

-A$2.22M

Free Cash Flow

-A$6.31M

Cash & ST Invst.

A$16.87M

Total Debt

A$3.33M

Medical Developments International Performance Analysis

Medical Developments International annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 15,914,945N/A
20232023-06-30AUD 21,753,24636.7%
20242024-06-30AUD 21,725,027-0.1%
20252025-06-30AUD 25,293,87616.4%
Medical Developments International sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3019.8%
Q22024-12-3110.6%
Q42025-06-30-4.6%
Q22025-12-3113.1%
Medical Developments International annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.12N/A
20232023-06-30AUD -0.04-64.0%
20242024-06-30AUD -0.30595.4%
20252025-06-30AUD 0.00N/A
Medical Developments International sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-183.3%
Q22024-12-31100.8%
Q42025-06-30-170.4%
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$21.56M

+43.0%

Gross Profit

A$6.71M

+223.1%

Gross Margin

31.13%

N/A

Market Cap

$41.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$612.99K

N/A

Employees

68

N/A

Net Income

-A$225.91K

+97.9%

EBITDA

A$1.33M

+111.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$16.87M

+7.5%

Total Debt

A$3.33M

+37.5%

Accounts Receivable

A$7.48M

+54.4%

Inventory

A$8.49M

-10.7%

Long Term Debt

A$3.00M

+45.8%

Short Term Debt

A$329.87K

-9.6%

Return on Assets

-0.69%

N/A

Return on Invested Capital

0.58%

N/A

Free Cash Flow

A$61.97K

+100.8%

Operating Cash Flow

A$283.89K

+104.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LEEEFLeef Brands Inc.
$0.19-0.47%
ITHUFiAnthus Capital Holdings, Inc.
$0.00+0.00%
SEOVFSernova Corp.
$0.08+2.50%
DSOLDrug Free Solution, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About MDDVF

What is the current price of Medical Developments International?

Medical Developments International is trading at $0.37 per share.

What is the 52-week range for Medical Developments International?

Over the past 52 weeks, Medical Developments International has traded between $0.30 and $0.37.

How much debt does Medical Developments International have?

As of the most recent reporting period, Medical Developments International reported total debt of A$1.30M.

How much cash does Medical Developments International have on hand?

Medical Developments International reported A$11.69M in cash and cash equivalents in its most recent financial results.

What is Medical Developments International’s dividend yield?

Medical Developments International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services